[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE503805C2 - N-Derivat av (fenyletyl-beta-ol)amin, ett förfarande för deras framställning och läkemedelskompositioner som innehåller desamma - Google Patents

N-Derivat av (fenyletyl-beta-ol)amin, ett förfarande för deras framställning och läkemedelskompositioner som innehåller desamma

Info

Publication number
SE503805C2
SE503805C2 SE9302437A SE9302437A SE503805C2 SE 503805 C2 SE503805 C2 SE 503805C2 SE 9302437 A SE9302437 A SE 9302437A SE 9302437 A SE9302437 A SE 9302437A SE 503805 C2 SE503805 C2 SE 503805C2
Authority
SE
Sweden
Prior art keywords
compound
trans
cis
nmr
tetrahydrofuran
Prior art date
Application number
SE9302437A
Other languages
English (en)
Swedish (sv)
Other versions
SE9302437L (sv
SE9302437D0 (sv
Inventor
Serge Auvin
Pierre Braquet
Colette Broquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of SE9302437D0 publication Critical patent/SE9302437D0/xx
Publication of SE9302437L publication Critical patent/SE9302437L/xx
Publication of SE503805C2 publication Critical patent/SE503805C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9302437A 1992-07-17 1993-07-16 N-Derivat av (fenyletyl-beta-ol)amin, ett förfarande för deras framställning och läkemedelskompositioner som innehåller desamma SE503805C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215274A GB9215274D0 (en) 1992-07-17 1992-07-17 Derivatives of(phenylethyl-beta-ol)amine

Publications (3)

Publication Number Publication Date
SE9302437D0 SE9302437D0 (sv) 1993-07-16
SE9302437L SE9302437L (sv) 1994-01-18
SE503805C2 true SE503805C2 (sv) 1996-09-09

Family

ID=10718914

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9302437A SE503805C2 (sv) 1992-07-17 1993-07-16 N-Derivat av (fenyletyl-beta-ol)amin, ett förfarande för deras framställning och läkemedelskompositioner som innehåller desamma

Country Status (32)

Country Link
US (1) US5447942A (xx)
JP (1) JP3204811B2 (xx)
AT (1) AT403693B (xx)
AU (1) AU672791B2 (xx)
BE (1) BE1006429A3 (xx)
CA (1) CA2100381C (xx)
CH (1) CH687705A5 (xx)
DE (1) DE4323976C2 (xx)
DK (1) DK84793A (xx)
DZ (1) DZ1704A1 (xx)
ES (1) ES2067417B1 (xx)
FI (1) FI933235A7 (xx)
FR (2) FR2693653B1 (xx)
GB (2) GB9215274D0 (xx)
GR (1) GR1001565B (xx)
HK (1) HK52596A (xx)
HU (1) HUT64757A (xx)
IE (1) IE73266B1 (xx)
IN (1) IN183086B (xx)
LU (1) LU88383A1 (xx)
MA (1) MA22937A1 (xx)
MY (1) MY109395A (xx)
NL (1) NL9301241A (xx)
NO (1) NO302946B1 (xx)
NZ (1) NZ248041A (xx)
OA (1) OA09838A (xx)
PL (1) PL173783B1 (xx)
PT (1) PT101308B (xx)
RU (1) RU2060252C1 (xx)
SE (1) SE503805C2 (xx)
TN (1) TNSN93081A1 (xx)
ZA (1) ZA934667B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006025920A2 (en) * 2004-06-19 2006-03-09 Human Biomolecular Research Institute Modulators of central nervous system neurotransmitters
WO2020148325A1 (en) 2019-01-15 2020-07-23 Phenex-Fxr Gmbh Neutral lxr modulators
GB202304652D0 (en) * 2023-03-29 2023-05-10 Atrogi Ab New compounds and medical uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700692A (en) 1971-06-04 1972-10-24 Colgate Palmolive Co 1-(4{40 -hydroxy-3{40 -(hydroxy methyl)-phenyl)-1-hydroxy-2-aralkylaminoethanes
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
NZ211822A (en) * 1984-04-17 1988-11-29 Glaxo Group Ltd Phenethanolamine derivatives and pharmaceutical compositions
DE3731198A1 (de) * 1987-02-07 1988-08-18 Bayer Ag 2-aminomethyltetrahydrofurane
JPS6485964A (en) * 1987-03-12 1989-03-30 Glaxo Group Ltd Compound
GB2230525A (en) * 1989-04-14 1990-10-24 Glaxo Group Ltd 1-(Hydroxyphenyl)-2-aminoethanol derivatives
GB2230775A (en) * 1989-04-24 1990-10-31 Glaxo Group Ltd Phenethanolamine compounds
PT95542B (pt) * 1989-10-10 1999-09-30 Glaxo Group Ltd Processo para a prparacao de derivados de fenetanolamina

Also Published As

Publication number Publication date
CA2100381C (en) 2004-09-21
HK52596A (en) 1996-04-03
PL299693A1 (en) 1994-03-21
GB9215274D0 (en) 1992-09-02
NO932383D0 (no) 1993-06-29
NO932383L (no) 1994-01-18
SE9302437L (sv) 1994-01-18
FR2693723B1 (fr) 1994-10-28
PL173783B1 (pl) 1998-04-30
RU2060252C1 (ru) 1996-05-20
US5447942A (en) 1995-09-05
DE4323976C2 (de) 2003-05-28
HU9302057D0 (en) 1993-10-28
FR2693653B1 (fr) 1994-10-28
SE9302437D0 (sv) 1993-07-16
GB2268742A (en) 1994-01-19
AT403693B (de) 1998-04-27
PT101308A (pt) 1994-05-31
ATA142793A (de) 1997-09-15
GB9314718D0 (en) 1993-08-25
NZ248041A (en) 1994-06-27
ES2067417A1 (es) 1995-03-16
NO302946B1 (no) 1998-05-11
DZ1704A1 (fr) 2002-02-17
GB2268742B (en) 1995-11-08
ES2067417B1 (es) 1995-11-16
OA09838A (fr) 1994-08-15
IE73266B1 (en) 1997-05-21
JP3204811B2 (ja) 2001-09-04
FR2693723A1 (fr) 1994-01-21
FI933235L (fi) 1994-01-18
DK84793A (da) 1994-01-18
NL9301241A (nl) 1994-02-16
GR1001565B (el) 1994-05-31
MY109395A (en) 1997-01-31
MA22937A1 (fr) 1994-04-01
CH687705A5 (fr) 1997-01-31
BE1006429A3 (fr) 1994-08-23
IN183086B (xx) 1999-09-04
FR2693653A1 (fr) 1994-01-21
DK84793D0 (da) 1993-07-16
JPH06157492A (ja) 1994-06-03
AU672791B2 (en) 1996-10-17
FI933235A7 (fi) 1994-01-18
ZA934667B (en) 1994-01-25
DE4323976A1 (de) 1994-01-20
HUT64757A (en) 1994-02-28
FI933235A0 (fi) 1993-07-16
CA2100381A1 (en) 1994-01-18
TNSN93081A1 (fr) 1994-03-17
LU88383A1 (fr) 1994-04-01
IE930472A1 (en) 1994-01-26
AU4204293A (en) 1994-01-20
PT101308B (pt) 1999-10-29

Similar Documents

Publication Publication Date Title
DE69429861T2 (de) Endothelin-rezeptor-antagonisten
Tanikaga et al. Stereochemical behavior of intermediary compounds in the amine-catalyzed Knoevenagel reaction.
DE69403084T2 (de) Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen
SE503805C2 (sv) N-Derivat av (fenyletyl-beta-ol)amin, ett förfarande för deras framställning och läkemedelskompositioner som innehåller desamma
Carter et al. Analogs of oxybutynin. Synthesis and antimuscarinic and bladder activity of some substituted 7-amino-1-hydroxy-5-heptyn-2-ones and related compounds
JPH10152460A (ja) ２−アミノ−１−（４−ヒドロキシ−２−メチルフェニル）プロパノール誘導体
Séquin 13C‐NMR. Spectral Differences between Corresponding Methyl Esters, Phenyl Esters and 2‐Substituted Chromones
US4982006A (en) Process for the preparation of certain substituted aromatic compounds
FR2645532A1 (fr) Composes ammonium quaternaire ayant une activite myorelaxante et leur procede de preparation
YAMATO et al. Chemical structure and sweet taste of isocoumarin and related compounds. IX
AU674657B2 (en) Orally active antiviral compounds
NL8103710A (nl) Heteroprostaglandine-derivaten en werkwijze voor de bereiding daarvan.
JPH0572906B2 (xx)
Kornet Synthesis and anticonvulsant activity of 2‐aryl‐3, 4‐dialkyltetrahydro‐1, 3, 4‐oxadiazines and 2‐aryl‐3, 4‐dialkyltetrahydro‐1, 3, 4‐oxadiazin‐5‐ones
Teodori et al. Synthesis and pharmacological evaluation of verapamil analogs with restricted molecular flexibility
HU194859B (en) Process for production of derivatives of 2-/2-tienil/ and 2-/3-tienil/-ethil-amin
EP0817782A1 (en) Phenyl derivatives useful as endothelin receptor antagonists
CA1194021A (en) Heteroprostaglandin derivatives and processes for preparing them
FI77027C (fi) Saett framstaellning av farmakologiskt verksam 1-/1-(3,4-dimetoxifenyl)-3-amino-propyl/-6,7-dimetoxi- isokinolinfoerening.
大和正利 et al. Chemical structure and sweet taste of isocoumarin and related compounds. IX.
GB2082176A (en) Heteroprostaglandin derivatives and processes for preparing them
Tubergen LEWIS ACID CATALYZED REARRANGEMENTS OF ALPHA, BETA EPOXY OXIMES AND A MECHANISTIC STUDY OF THE ANIONIC OXY-COPE REARRANGEMENT
NL8502212A (nl) Fenethanolaminederivaten.
CZ288244B6 (en) Process for preparing phosphonium salts
SE177655C1 (xx)

Legal Events

Date Code Title Description
NUG Patent has lapsed